Next Arc Research

Not logged in? You're viewing the Free tier. Join for free or log in to access your membership content.
Disclaimer: This content is for informational and educational purposes only and should not be construed as financial or investment advice. Always do your own research and consult a licensed financial advisor before making investment decisions.
Disclosure: The author holds a long position in BFLY.
← Back to Free Index

BFLY

Analysis as of: 2026-02-20
Butterfly Network, Inc.
Butterfly Network sells handheld ultrasound probes plus cloud software subscriptions and services to clinicians and health systems.
ai hardware healthcare medical devices software
On Yahoo Finance ...
Jump to: Summary • Analysis • Opportunity • Risk • Trends • LE Structure • Third Party Analyst Consensus

Summary

Handheld ultrasound becomes an enterprise workflow wedge
A 3x EV path is plausible if probe distribution converts into facility-level recurring workflow revenue and margins stabilize. The main failure mode is bundled competition plus dilution before scale.

Analysis

Thesis
Non-linear upside comes if handheld ultrasound becomes a governed clinical workflow: probes seed distribution, then hospitals pay per facility/pathway for evidence capture, QA, security, and documentation—durable even as AI makes interpretation cheap.
Last Economy Alignment
AI expands who can safely acquire scans, growing point-of-care ultrasound volume, but value capture shifts toward trust, auditability, and workflow embedding (not “AI interpretation”). Butterfly can win if it becomes the compliance-grade system of record; it loses if incumbents bundle and subscriptions deflate.
Upgrade to Allocator to also access: Thesis Critique

Opportunity Outlook

Average Implied 5-Year Multiple
3.4x (from 5 most recent analyses)
Reasoning
The stock works if Butterfly stops being underwritten as a niche device vendor and becomes a repeatable enterprise rollout: more probes per health system, higher recurring attach, and pricing that moves from per-user to per-facility / per-pathway bundles (governance, audit, storage, documentation, integrations). Recent security/compliance progress is a real enterprise wedge; the gating risks are credentialing/training throughput and incumbent bundling.
Upgrade to Allocator to also access: Simplified Opportunity Explanation

Risk Assessment

Overall Risk Summary
The business is structurally gated by (1) funding/dilution until self-funding economics are durable and (2) the speed at which institutions can credential/train users and operationalize QA. Competitive risk is acute: if incumbents bundle handheld devices into existing enterprise imaging contracts, Butterfly’s per-user subscription capture can deflate unless it owns a compliance/workflow control point that procurement will pay for.
Upgrade to Allocator to also access: Tech Maturity Risk Score, Adoption Timing Risk Score, Moat Strength Risk Score, Capital Needs Risk Score, Regulatory Risk Score, Execution Risk Score, Concentration Risk Score, Unit Economics Risk Score, Valuation Risk Score, Macro Sensitivity Risk Score

Last Economy Structure

AI Industrial Score
0.30
They control a low-cost ultrasound probe that can spread quickly, and the cloud workflow can become the trusted audit trail hospitals must keep. The risk is incumbents bundling and slow credentialing cycles, which can stall scale before cash burn ends.
Upgrade to Reader to also access: Score Decomposition, Confidence Level
Upgrade to Allocator to also access: Obsolescence Vectors, Pricing Fragility
Upgrade to Reader to also access: Constraint Benefit Score, Obsolescence Risk Score

Third Party Analyst Consensus

12-Month Price Target
$5.06
Upgrade to Reader to also access: Bull Case, Base Case, Bear Case